These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. An Update From the American Stroke Association and the Stroke Council. Schwamm LH; Panagos PD; Mohl SM Stroke; 2021 Jun; 52(6):e269-e271. PubMed ID: 33980043 [No Abstract] [Full Text] [Related]
48. Encephalitis as a neurological complication of COVID-19: A systematic review and meta-analysis of incidence, outcomes, and predictors. Siow I; Lee KS; Zhang JJY; Saffari SE; Ng A Eur J Neurol; 2021 Oct; 28(10):3491-3502. PubMed ID: 33982853 [TBL] [Abstract][Full Text] [Related]
49. From cellular function to global impact: the vascular perspective on COVID-19. Strauss SA; Seo C; Carrier M; Jetty P Can J Surg; 2021 May; 64(3):E289-E297. PubMed ID: 33978563 [TBL] [Abstract][Full Text] [Related]
50. Cerebral Venous Thrombosis Associated with COVID-19 Infection: An Observational, Multicenter Study. Hameed S; Wasay M; Soomro BA; Mansour O; Abd-Allah F; Tu T; Farhat R; Shahbaz N; Hashim H; Alamgir W; Iqbal A; Khan M Cerebrovasc Dis Extra; 2021; 11(2):55-60. PubMed ID: 33975306 [TBL] [Abstract][Full Text] [Related]
51. The role of sex and inflammation in cardiovascular outcomes and mortality in COVID-19. Minhas AS; Shade JK; Cho SM; Michos ED; Metkus T; Gilotra NA; Sharma G; Trayanova N; Hays AG Int J Cardiol; 2021 Aug; 337():127-131. PubMed ID: 33974962 [TBL] [Abstract][Full Text] [Related]
52. Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. Chou SH; Beghi E; Helbok R; Moro E; Sampson J; Altamirano V; Mainali S; Bassetti C; Suarez JI; McNett M; JAMA Netw Open; 2021 May; 4(5):e2112131. PubMed ID: 33974053 [TBL] [Abstract][Full Text] [Related]
53. Neurologic Manifestations of COVID-19. Delavari F; Varzaneh FN; Rezaei N Adv Exp Med Biol; 2021; 1318():343-353. PubMed ID: 33973188 [TBL] [Abstract][Full Text] [Related]
54. COVID-19 - neuropathological point of view, pathobiology, and dilemmas after the first year of the pandemic struggle. Sieracka J; Sieracki P; Kozera G; Szurowska E; Gulczyński J; Sobolewski P; Kloc W; Iżycka-Świeszewska E Folia Neuropathol; 2021; 59(1):1-16. PubMed ID: 33969672 [TBL] [Abstract][Full Text] [Related]
55. Stroke and neurointervention in the COVID-19 pandemic: a narrative review. Rana A; Nguyen TN; Siegler JE Expert Rev Med Devices; 2021 Jun; 18(6):523-531. PubMed ID: 33966557 [No Abstract] [Full Text] [Related]
58. Emergency department visits for emergent conditions among older adults during the COVID-19 pandemic. Janke AT; Jain S; Hwang U; Rosenberg M; Biese K; Schneider S; Goyal P; Venkatesh AK J Am Geriatr Soc; 2021 Jul; 69(7):1713-1721. PubMed ID: 33955546 [TBL] [Abstract][Full Text] [Related]
59. Social Determinants of Adherence to COVID-19 Risk Mitigation Measures Among Adults With Cardiovascular Disease. Hagan KK; Javed Z; Cainzos-Achirica M; Sostman D; Vahidy FS; Valero-Elizondo J; Acquah I; Yahya T; Kash B; Andrieni JD; Dubey P; Hyder AA; Nasir K Circ Cardiovasc Qual Outcomes; 2021 Jun; 14(6):e008118. PubMed ID: 33955228 [TBL] [Abstract][Full Text] [Related]
60. The relationship between COVID-19's severity and ischemic stroke: a systematic review and meta-analysis. Lu Y; Zhao JJ; Ye MF; Li HM; Yao FR; Kong Y; Xu Z Neurol Sci; 2021 Jul; 42(7):2645-2651. PubMed ID: 33954827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]